1.Feeny, D, Wu, L, Eng, K (2004) Comparing short form 6D, standard gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: Results from total hip arthroplasty patients. Qual Life Res 13, 1659–1670.
2.Santana, MJ, Feeny, D, Johnson, JA, et al. (2010) Assessing the use of health-related quality-of-life measures in the routine care of lung-transplant patients. Qual Life Res 19, 371–379.
3.Fryback, D, Dunham, NC, Palta, M, et al. (2007) U.S. norms for six generic health-related quality of life indexes from the National Health Measurement Study. Med Care 45, 1162–1170.
7.Henry, D (1992) Economic analysis as an aid to subsidisation decisions: The development of Australian guidelines for pharmaceuticals [review]. Pharmacoeconomics 1, 54–67.
8.Shiroiwa, T, Fukuda, T, Ikeda, S, Takura, T, Moriwaki, K (2017) Development of an official guideline for economic evaluation of drugs/medical devices in Japan. Value Health 20, 372–378.
9.Neumann, PJ, Sanders, GD, Russell, LB, Siegel, JE, Ganiats, TG, eds (2017) Cost-effectiveness in health and medicine. 2nd ed. New York: Oxford University Press.
10.Feeny, D, Krahn, M, Prosser, LA, Salomon, JA (2017) Valuing health outcomes. In: Neumann, PJ, Sanders, GD, Russell, LB, Siegel, JE, Ganiats, TG, eds. Cost-effectiveness in health and medicine. 2nd ed. New York: Oxford University Press; p. 167–199.
11.Rabin, R, de Charro, F (2001) EQ-5D: A measure of health status from the EuroQol Group. Ann Med 33, 337–343.
12.Torrance, GW, Feeny, DH, Furlong, WJ, et al. (1996) Multi-attribute preference functions for a comprehensive health status classification system: Health Utilities Index Mark 2. Med Care 34, 702–722.
13.Furlong, W, Feeny, DH, Torrance, GW, Barr, RD (2001) The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 33, 375–384.
14.Kaplan, RM, Anderson, JP (1996) The general health policy model: An integrated approach. In: Spilker, B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia: Lippincott-Raven Press; p. 309–322.
15.Brazier, J, Roberts, J, Deverill, M (2002) The estimation of a preference-based measure of health status from the SF-36. J Health Econ 21, 271–292.
16.Brazier, JE, Roberts, J (2004) The estimation of a preference-based measure of health from the SF-12. Med Care 42, 851–859.
17.Gamst-Klaussen, T, Chen, G, Lamu, AN, Olsen, JA (2016) Health state utility instruments compared: Inquiring into nonlinearity across EQ-5D-5L, SF-6D, HUI-3 and 15D. Qual Life Res 25, 1667–1678.
18.Chen, G, Khan, MA, Iezzi, A, Ratcliffe, J, Richardson, J (2016) Mapping between 6 multiattribute utility instruments. Med Decis Making 36, 160–175.
19.Fayers, PM, Machin, D (2016) Quality of life: Assessment, analysis and reporting of patient-reported outcomes. 3rd ed. Chichester: John Wiley & Sons.
21.Guyatt, GH, Osoba, D, Wu, AW, Wyrwich, K, Norman, GR; Clinical Significance Consensus Meeting Group (2002) Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77, 371–383.
22.Schünemann, HJ, Guyatt, GH (2005) Commentary - Goodbye M(C)ID! Hello MID, where do you come from? Health Serv Res 40, 593–597.
23.Marra, CA, Woolcott, JC, Kopec, JA, et al. (2005) A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 60, 1571–1582.
24.Marra, CA, Rashidi, AR, Guy, D, et al. (2005) Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res 14, 1333–1344.
25.Fryback, DG, Palta, M, Cherepanov, D, Bolt, D, Kim, J-S (2010) Comparison of five health-related quality-of-life indexes using item response theory analysis. Med Decis Making 30, 5–15.
26.Lynch, FL, Dickerson, JF, Feeny, DH, Clarke, GN, MacMillan, AL (2016) Measuring health-related quality of life in teens with and without depression.” Med Care 54, 1089–1097.
27.Dickerson, JF, Feeny, DH, Clarke, GN, MacMillan, AL, Lynch, FL (2018) Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression. Qual Life Res 27, 447–454.
28.Langfitt, JT, Vickery, BG, McDermott, MP, et al. (2006) Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy. Qual Life Res 15, 899–914.
29.Pickard, AS, Johnson, JA, Feeny, DH (2005) Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res 14, 207–219.
30.Feeny, D, Spritzer, K, Hays, RD, et al. (2012) Agreement about identifying patients who change over time: Cautionary results in cataract and heart failure patients. Med Decis Making 32, 273–286.
31.Feeny, D (2013) Standardization and regulatory guidelines may inhibit science and reduce the usefulness of analyses based on the application of preference-based measures for policy decisions. Med Decis Making 33, 316–319.
32.Wiebe, S, Guyatt, G, Weaver, B, Matijevic, S, Sidwell, C (2003) Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 56, 52–60.
33.Yang, Y, Brazier, J, Tsuchiya, A (2014) Effect of adding a sleep dimension to the EQ-5D descriptive system: A ‘bolt-on’ experiment. Med Decis Making 34, 42–53.
34.Drummond, MF, Sculpher, MJ, Torrance, GW, O'Brien, B, Stoddart, GL (2005) Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press.
35.Gold, MR, Patrick, DL, Torrance, GW, et al. (1996) Identifying and valuing outcomes. In: Gold, MR, Siegel, JE, Russell, LB, Weinstein, MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press.
36.Richardson, J, Khan, MA, Iezzi, A, Maxwell, A (2015) Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI3, 15D, QWB, and AQoL-8D multiattribute utility instruments. Med Decis Making 35, 276–291.
37.Richardson, J, McKie, J, Bariola, E (2014) Multiattribute Utility Instruments and their use. In: Culyer, AJ, ed., Encyclopedia of health economics. vol 2. San Diego: Elsevier; pp. 341–357.
38.Brazier, J, Ara, R, Rowen, Donna, Chevrou-Severac, H (2017) A review of generic preference-based measures for use in cost-effectiveness models. Pharmacoeconomics 35, S21–S31.
39.Devlin, N, Shah, KS, Feng, Y et al. (2018) Valuing health-related quality of life: An EQ-5D-3L value set for England. Health Econ 27, 7–22.
40.Dewitt, B, Feeny, D, Cella, D, et al. (2018) Estimation of a single preference-based summary score for the patient reported outcomes measurement information system: The PROMIS-Preference (PROPr) Score. Med Decis Making 38, 683–698.
41.Sintonen, H (2001) The 15D instrument of health-related quality of life: Properties and applications. Ann Med 33, 328–336.